Syndax Pharmaceuticals Inc

WALTHAM, MA How do I update this listing?

Syndax Pharmaceuticals is based out of Waltham. Syndax Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company offers therapies to treat solid tumors and lung, breast, and hematological cancer. Syndax Pharmaceuticals serves the medical and healthcare sectors in the United States.Whalewisdom has at least 51 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2015-08-28. The notice included securities offered of Equity

Create Alert

Contact Info

syndax pharmaceuticals inc
35 GATEHOUSE DRIVE
WALTHAM MA    02451

Business Phone: 781-419-1400
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2015-08-28 D PHARMACEUTICALS Equity 61,252,462 61,252,462 0
2015-06-15 D PHARMACEUTICALS Equity 45,211,064 23,961,064 21,250,000
2014-09-19 D PHARMACEUTICALS Debt,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 5,000,000 4,947,480 52,520
2014-02-13 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security 1,270,093 1,270,093 0
2014-02-13 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security 1,728,471 1,728,471 0
2013-11-14 D PHARMACEUTICALS Equity 50,000 50,000 0
2013-08-30 D PHARMACEUTICALS Equity 48,411,733 31,330,958 17,080,775
2010-08-05 D PHARMACEUTICALS Debt,Option, Warrant or Other Right to Acquire Another Security 7,007,000 6,006,000 1,001,000
2010-02-03 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security 16,000,000 9,000,000 7,000,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ARLENE MORRIS subscription required
    EXECUTIVE OFFICER DIRECTOR
BRIGGS MORRISON, M.D. subscription required
    EXECUTIVE OFFICER DIRECTOR
DENNIS PODLESAK subscription required
    DIRECTOR
FABRICE EGROS subscription required
    DIRECTOR
FABRICE EGROS, PH.D. subscription required
    DIRECTOR
GEORGE W SLEDGE, JR. M.D. subscription required
    DIRECTOR
GEORGE W SLEDGE, JR., M.D. subscription required
    DIRECTOR
HENRY CHEN subscription required
    DIRECTOR
IVOR ROYSTON subscription required
    DIRECTOR
IVOR ROYSTON, M.D. subscription required
    DIRECTOR
JOANNA HOROBIN, M.D. subscription required
    DIRECTOR EXECUTIVE OFFICER
JOHN PALLIES subscription required
    EXECUTIVE OFFICER
KIM KAMDAR, PH.D subscription required
    DIRECTOR
KIM KAMDAR, PH.D. subscription required
    DIRECTOR
KIM KAMDAR, PHD subscription required
    DIRECTOR
LUKE EVNIN, PH.D. subscription required
    DIRECTOR
MICHAEL METZGER subscription required
    EXECUTIVE OFFICER
RICHARD P SHEA subscription required
    DIRECTOR
ROBERT GOODENOW, PH.D. subscription required
    EXECUTIVE OFFICER
ROBERT GOODENOW, PHD subscription required
    EXECUTIVE OFFICER
ROSINA MAAR PAVIA, M.D. subscription required
    DIRECTOR
STEVEN ST. PETER, M.D. subscription required
    DIRECTOR

Elevate your investments